Immatics N.V. (IMTX) stock experienced a decline on Thursday following the announcement of a $150 million public offering. However, the company also shared promising Phase 1b data for its IMA203 TCR-T therapy targeting PRAME in melanoma patients, indicating potential for a significant breakthrough in the treatment of this aggressive cancer.
NuCana plc presented promising data from its Phase 2 NuTide:701 study, showcasing the potential of NUC-7738 in combination with Merck’s Keytruda for treating metastatic melanoma. The combination showed encouraging efficacy signals and a favorable safety profile in patients who had previously failed PD-1 inhibitor therapies.
This article addresses common questions about sunscreen use, dispelling myths and emphasizing its crucial role in preventing skin cancer and premature aging. It also provides information on the signs of melanoma, stressing the importance of regular skin checks.
A young woman shares her harrowing experience with skin cancer, highlighting the dangers of sunbed use and urging others to prioritize their health. Her story serves as a stark reminder of the long-term consequences of excessive sun exposure and tanning.
Skin cancer diagnoses in the UK have reached a record high, with 20,800 people expected to be diagnosed with melanoma this year. The rates have increased by almost a third over the past decade. While anyone can get skin cancer, those with fair complexions are at a higher risk, but people with darker skin tones can also be affected. To prevent skin cancer, it’s important to limit exposure to ultraviolet (UV) radiation, check your skin regularly for any changes, and see your doctor if you notice any unusual moles or skin lesions.
